APA (7th ed.) Citation

Smith, P. F., Robbins, G. K., Shafer, R. W., Wu, H., Yu, S., Hirsch, M. S., . . . Morse, G. D. (2005). Pharmacokinetics of Nelfinavir and Efavirenz in Antiretroviral-Naïve, Human Immunodeficiency Virus-Infected Subjects when Administered Alone or in Combination with Nucleoside Analog Reverse Transcriptase Inhibitors. Antimicrobial Agents and Chemotherapy, 49(8), 3558-3561. https://doi.org/10.1128/AAC.49.8.3558-3561.2005

Chicago Style (17th ed.) Citation

Smith, Patrick F., et al. "Pharmacokinetics of Nelfinavir and Efavirenz in Antiretroviral-Naïve, Human Immunodeficiency Virus-Infected Subjects When Administered Alone or in Combination with Nucleoside Analog Reverse Transcriptase Inhibitors." Antimicrobial Agents and Chemotherapy 49, no. 8 (2005): 3558-3561. https://doi.org/10.1128/AAC.49.8.3558-3561.2005.

MLA (9th ed.) Citation

Smith, Patrick F., et al. "Pharmacokinetics of Nelfinavir and Efavirenz in Antiretroviral-Naïve, Human Immunodeficiency Virus-Infected Subjects When Administered Alone or in Combination with Nucleoside Analog Reverse Transcriptase Inhibitors." Antimicrobial Agents and Chemotherapy, vol. 49, no. 8, 2005, pp. 3558-3561, https://doi.org/10.1128/AAC.49.8.3558-3561.2005.